Clinical Trials in Chicago

Showing 5121-5140 of 20,493 trials

Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma

NCT03117309

Phase II trial of nivolumab in 120 treatment naïve patients with ccRCC.

Michael B. Atkins, MD164 participantsStarted Apr 2017

New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States • Atlanta, Georgia, United States +9 more locations

Active Not RecruitingNA2.2 miles

Elements Vital to Treat Obesity Study

NCT04708769

The overall objective of this study is to evaluate the first rigorously optimized, remotely delivered treatment for obesity against the current gold standard treatment in a head-to-head randomized controlled trial. The investigators will be comparing the previously developed and optimized behavioral weight loss intervention (APP) to the Diabetes Prevention Program (DPP), to evaluate program weight-loss success and cost-effectiveness.

Obesity

Northwestern University524 participantsStarted Mar 2021

Chicago, Illinois, United States

Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma

Elements Vital to Treat Obesity Study

Find Trials by Condition in Chicago

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis

The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy

An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution

A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder

A Study in Participants With Non-cirrhotic NASH With Fibrosis

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)

AutoInflammatory Disease Alliance Registry (AIDA)